The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.
Tumor Microenvironment - New York City Second Annual Symposium More
New ACGME-approved, Thoracic Surgery Residency position "tracked" towards General Thoracic Surgery More
Researchers reveal How Cancer Cells Change Once They Spread to Distant Organs. More